These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25039933)

  • 21. Plasma derivatives: new products and new approaches.
    Sauna ZE; Pandey GS; Jain N; Mahmood I; Kimchi-Sarfaty C; Golding B
    Biologicals; 2012 May; 40(3):191-5. PubMed ID: 22239993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood safety.
    Mant S; Smith MP
    N Z Med J; 2013 May; 126(1374):10-1. PubMed ID: 23799377
    [No Abstract]   [Full Text] [Related]  

  • 23. Approaches to plasma fractionation for improved recovery and the development of potentially useful clinical factors.
    Johnson AJ; Mathews RW; Fulton AJ
    Clin Haematol; 1984 Feb; 13(1):3-15. PubMed ID: 6426834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemophilia: the blood bank's concern?].
    Smit Sibinga CT
    Ned Tijdschr Geneeskd; 1978 Sep; 122(37):1359-62. PubMed ID: 692762
    [No Abstract]   [Full Text] [Related]  

  • 25. [Various methods for good blood supply in Scandinavia].
    Oldinger E
    Nord Med; 1996 Sep; 111(7):212-8. PubMed ID: 8927533
    [No Abstract]   [Full Text] [Related]  

  • 26. Concerns raised over poor blood safety systems in India.
    Sharma DC
    Lancet; 2016 Jun; 387(10036):2369. PubMed ID: 27312294
    [No Abstract]   [Full Text] [Related]  

  • 27. [Long-term follow-up of consumption of plasma, blood and antihemophilic globulin in patients with hemophilia].
    Pudlák P; Horák J
    Vnitr Lek; 1968 Jan; 15(1):1-8. PubMed ID: 5720983
    [No Abstract]   [Full Text] [Related]  

  • 28. [Indications and transfusion of coagulation-active blood fractions].
    Mueller-Eckhardt C; Heinrich D; Lasch HG
    Z Prakt Anasth; 1970 Dec; 5(6):401-18. PubMed ID: 4256253
    [No Abstract]   [Full Text] [Related]  

  • 29. The safety of blood components and derivatives.
    Julius C; Westphal RG
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1057-77. PubMed ID: 1400072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Material & equipment, procurement & maintenance: Impact on blood safety.
    Emmanuel JC
    Biologicals; 2010 Jan; 38(1):78-80. PubMed ID: 20079663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Blood safety in Mexico. Achievements and challenges].
    Sánchez-Guerrero SA
    Rev Invest Clin; 2011; 63(3):309-13. PubMed ID: 21888294
    [No Abstract]   [Full Text] [Related]  

  • 32. A second look at the fresh frozen plasma: packed red blood cell ratio in massive transfusion protocols.
    Vandromme MJ; Snyder CW; McGwin G; Weinberg JA; Kerby JD
    J Am Coll Surg; 2010 Jan; 210(1):117; author reply 117-8. PubMed ID: 20123343
    [No Abstract]   [Full Text] [Related]  

  • 33. Closing the circle: a thirty-year retrospective on the AIDS/blood epidemic.
    Dubin C; Francis D
    Transfusion; 2013 Oct; 53(10 Pt 2):2359-64. PubMed ID: 24032638
    [No Abstract]   [Full Text] [Related]  

  • 34. The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy framework.
    Moltzan CJ; Anderson DA; Callum J; Fremes S; Hume H; Mazer CD; Poon MC; Rivard G; Rizoli S; Robinson S
    Transfus Med; 2008 Apr; 18(2):112-20. PubMed ID: 18399845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Product delivery in the developing world: options, opportunities and threats.
    Farrugia A
    Haemophilia; 2004 Oct; 10 Suppl 4():77-82. PubMed ID: 15479376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of medication taken by blood donors in plasma for transfusion.
    van Tilborgh-de Jong AJ; Wiersum-Osselton JC; Touw DJ; Schipperus MR
    Vox Sang; 2015 May; 108(4):323-7. PubMed ID: 25557151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expert Consensus Statement on achieving self-sufficiency in safe blood and blood products, based on voluntary non-remunerated blood donation (VNRBD).
    WHO Expert Group
    Vox Sang; 2012 Nov; 103(4):337-42. PubMed ID: 22690746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Product liability for defective blood.
    Newdick C
    Haematologia (Budap); 1994; 26(1):49-53. PubMed ID: 7959375
    [No Abstract]   [Full Text] [Related]  

  • 39. [In-vivo control of blood coagulation fractions].
    Richter K; Rex JO; Stinner G; Fünfhausen G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):344-8. PubMed ID: 4195280
    [No Abstract]   [Full Text] [Related]  

  • 40. [Organizational problems in the production of therapeutic preparations using donors' blood].
    Gavrilov OK; Rusanov VM
    Sov Med; 1983; (4):82-4. PubMed ID: 6867840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.